fasudil has been researched along with Proliferative Vitreoretinopathy in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kita, T | 2 |
| Hata, Y | 1 |
| Arita, R | 1 |
| Kawahara, S | 1 |
| Miura, M | 1 |
| Nakao, S | 1 |
| Mochizuki, Y | 1 |
| Enaida, H | 1 |
| Goto, Y | 1 |
| Shimokawa, H | 1 |
| Hafezi-Moghadam, A | 1 |
| Ishibashi, T | 1 |
1 review available for fasudil and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
[Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Diabetic Retinopathy; Molecular Targeted The | 2010 |
1 other study available for fasudil and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Blotting, Western; Immunohistochemis | 2008 |